Select Your Region

We noticed you visit this page from United States. Please select your preferred region to continue.

skip to content

Country Selector

Based on your location

Europe

North America

Latin America

Asia-Pacific

Healthcare Sector Verification

This section contains information intended for healthcare professionals.

Please confirm that you are affiliated with a healthcare organization.

Rethinking PR3-ANCA Testing: A Novel High-Sensitivity ELISA

High-sensitivity immunoassay technology for anti-PR3 ANCA detection

Published: 10/23/2026 | Modified: 11/16/2026
  • PR3 is a key biomarker in ANCA-associated vasculitis, supporting diagnostic evaluation, particularly in Granulomatosis with Polyangiitis.
  • Innovation in assay design: A novel high-sensitivity ELISA approach aims to enhance the detection of antibodies directed against proteinase 3.
  • Analytical performance matters: Explore the study findings on the analytical performance of a novel high-sensitivity ELISA for anti-PR3 detection.

Test associated with this resource

  • Anti-PR3

    • Vasculitis
    • SMC Technology
    • ELISA
    • CLIA

Related instruments

Discover more resources on Vasculitis

This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.